Protalix BioTherapeuticsvsThermo Fisher Scientific

PLX and TMO stock compared: price, dividend, valuation and results, from SEC filings.

PLX

Protalix BioTherapeutics, Inc.

$3.05

Value $246M

+3.04%
PLX's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Protalix BioTherapeutics (PLX) has a market value of $246M and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, PLX moved +42.5% and TMO +19.5%. The P/E is 12.0 for PLX and 36.8 for TMO. Dividend yield: PLX none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PLX$246M

    TMO$260B

    TMO is 1,059 times PLX

  • Revenue, 12 months

    PLX$85M

    TMO$47.4B

    TMO is 559 times PLX

  • Net income, 12 months

    PLX$21M

    TMO$7.1B

    TMO is 344 times PLX

  • Operating margin

    PLX29.8%

    TMO17.9%

    11.9 points apart

  • ROIC

    PLX31.3%

    TMO8.2%

    23.1 points apart

  • P/E

    PLX12.0

    TMO36.8

    TMO is 3.1 times PLX

  • Dividend yield

    PLX0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    PLX+167.5%

    TMO+11.8%

    155.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PLX+167.6%

TMO+11.8%

10020020222023202420252026
Returns by period
PeriodPLXWith dividendsTMOWith dividends
1 year since November 12, 2025+42.5%Price +42.5%+19.5%Price +19.1%
3 years since November 13, 2023+125.9%+31.2% a yearPrice +125.9%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021+167.5%+21.8% a yearPrice +167.5%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016-41.3%-5.2% a yearPrice -41.3%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PLXProtalix BioTherapeuticsTMOThermo Fisher Scientific

Valuation

PLXTMO
Valuation
Price$3.05$700.22
Market value$246M$260B
Enterprise value (EV)$224M$295B
P/E12.036.8
P/E, 5-year median–32.7
P/B3.14.8
EV/EBIT8.934.9
Free cash flow yield6.1%2.9%

Results and growth

PLXTMO
Results and growth
Revenue, 12 months$85M$47.4B
Net income, 12 months$21M$7.1B
Free cash flow, 12 months$15M$7.6B
Earnings per share, 12 months$0.25$18.96
Revenue growth, year on year-1.2%3.9%
Revenue growth a year, past-3.5%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

PLXTMO
Margins and returns on capital
Gross margin71.2%–
Operating margin29.8%17.9%
Net margin24.3%14.9%
ROIC31.3%8.2%
ROE32.1%13.4%

Balance sheet

PLXTMO
Balance sheet
Cash$22M$6.1B
Total debt$9.1M$41.4B
Net debt / EBITDA-0.83.7
Interest cover–5.5×

Dividends and buybacks

PLXTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PLX or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Protalix BioTherapeutics or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 1,058.5 times Protalix BioTherapeutics ($246M), at today's prices.

How did PLX and TMO stock do over the last 10 years?

Since November 15, 2016, PLX's price moved -41.3% and TMO's +371.0%. With dividends: PLX -41.3% (-5.2% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, PLX or TMO?

The dividend yield at today's price is none for Protalix BioTherapeutics and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of PLX and TMO?

At today's price, the P/E is 12.0 for PLX and 36.8 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Protalix BioTherapeutics or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 24.3% for Protalix BioTherapeutics and 14.9% for Thermo Fisher Scientific, and the operating margin 29.8% and 17.9%. Revenue was $85M and $47.4B.

Which is the better investment, Protalix BioTherapeutics or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.